HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) Removed old template contents |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion}} | {{DISPLAYTITLE:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 15: | Line 14: | ||
Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||